Robert L. Wendt

783 total citations
33 papers, 615 citations indexed

About

Robert L. Wendt is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Robert L. Wendt has authored 33 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 8 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Robert L. Wendt's work include Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Robert L. Wendt is often cited by papers focused on Heart Failure Treatment and Management (6 papers), Cardiac electrophysiology and arrhythmias (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Robert L. Wendt collaborates with scholars based in United States, Canada and Germany. Robert L. Wendt's co-authors include Rodney W. Lappe, Jos F.M. Smits, Jacques Debets, Ronald J. McCaully, Allen T. Shropshire, Mark J. Slivjak, James L. Bergey, J. McCallum, Paul J. Silver and Frederick J. Bex and has published in prestigious journals such as Circulation Research, Hypertension and Journal of Medicinal Chemistry.

In The Last Decade

Robert L. Wendt

30 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert L. Wendt United States 14 310 194 123 87 66 33 615
S. Kazda Germany 14 297 1.0× 193 1.0× 71 0.6× 147 1.7× 39 0.6× 23 536
S. F. Flaim United States 19 406 1.3× 222 1.1× 85 0.7× 199 2.3× 99 1.5× 47 858
Kozo Yao Japan 14 172 0.6× 172 0.9× 37 0.3× 127 1.5× 34 0.5× 27 598
R. A. Ferrone United States 12 188 0.6× 140 0.7× 69 0.6× 94 1.1× 59 0.9× 13 498
Bühler Fr Switzerland 14 320 1.0× 199 1.0× 63 0.5× 155 1.8× 44 0.7× 75 707
A. Van de Water Belgium 13 651 2.1× 386 2.0× 64 0.5× 112 1.3× 29 0.4× 24 959
R. Testa Italy 18 186 0.6× 285 1.5× 200 1.6× 166 1.9× 35 0.5× 49 908
B Garthoff Germany 9 187 0.6× 126 0.6× 82 0.7× 85 1.0× 26 0.4× 18 423
Erich O. Mikkelsen Denmark 14 181 0.6× 191 1.0× 92 0.7× 180 2.1× 15 0.2× 37 483
Morley C. Sutter Canada 16 229 0.7× 212 1.1× 101 0.8× 215 2.5× 24 0.4× 39 731

Countries citing papers authored by Robert L. Wendt

Since Specialization
Citations

This map shows the geographic impact of Robert L. Wendt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Wendt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Wendt more than expected).

Fields of papers citing papers by Robert L. Wendt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Wendt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Wendt. The network helps show where Robert L. Wendt may publish in the future.

Co-authorship network of co-authors of Robert L. Wendt

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Wendt. A scholar is included among the top collaborators of Robert L. Wendt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Wendt. Robert L. Wendt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wendt, Robert L., et al.. (2004). Indoor air quality of an energy-efficient, healthy house with mechanically induced fresh air. 7 indexed citations
3.
Ibrahim, E. A., et al.. (2004). Thermal performance characteristics of an energy-efficient, healthy house. 3 indexed citations
4.
Koomey, Jonathan, et al.. (1997). The potential for energy-efficient technologies to reduce carbon emissions in the United States: buildings sector. ii. 2120–2125 vol.3. 3 indexed citations
5.
Greenwood, J. M., et al.. (1990). Effects of Atrial Natriuretic Factor in Conscious Rhesus Monkeys With Acute Volume Expansion. American Journal of Hypertension. 3(4). 262–267. 6 indexed citations
6.
Silver, Paul J., Richard L. Fenichel, & Robert L. Wendt. (1988). Structural Variants of Verapamil and W-7 with Combined Ca2+ Entry Blockade/Myosin Phosphorylation Inhibitory Mechanisms. Journal of Cardiovascular Pharmacology. 11(3). 299–307. 6 indexed citations
7.
Lappe, Rodney W., et al.. (1988). Cardiovascular Effects of Central Calcitonin Gene — Related Peptide in Conscious Rats. American Journal of Hypertension. 1(1). 47–49. 4 indexed citations
8.
Lappe, Rodney W., et al.. (1987). Hemodynamic effects of calcitonin gene-related peptide in conscious rats. Regulatory Peptides. 19(5-6). 307–312. 27 indexed citations
9.
Colatsky, Thomas, et al.. (1987). Cellular Electrophysiology of the New Antiarrhythmic Agent Recainam (Wy-42,362) in Canine Cardiac Purkinje Fibers. Journal of Cardiovascular Pharmacology. 9(4). 435–444. 9 indexed citations
10.
Lappe, Rodney W., et al.. (1987). Regional vasodilator actions of calcitonin gene-related peptide in conscious SHR. Peptides. 8(4). 747–749. 33 indexed citations
11.
Bex, Frederick J., et al.. (1987). HYPOTENSIVE RESPONSE TO ATRIAL NATRIURETIC FACTOR IN CONSCIOUS RENAL HYPERTENSIVE BEAGLES. Clinical and Experimental Pharmacology and Physiology. 14(2). 137–140. 2 indexed citations
12.
Lappe, Rodney W., et al.. (1986). Effects of fenoldopam on regional vascular resistance in conscious spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 187–191. 29 indexed citations
13.
Lappe, Rodney W., et al.. (1986). Hemodynamic effects of infusion versus bolus administration of atrial natriuretic factor.. Hypertension. 8(10). 866–873. 30 indexed citations
14.
Wendt, Robert L., et al.. (1986). Pharmacology of a Synthetic Human Atrial Natriuretic Factor, Wy-47,663 (Wy). Journal of Cardiovascular Pharmacology. 8(6). 1308–1308. 1 indexed citations
15.
Lappe, Rodney W., et al.. (1985). Graded regional vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 235(3). 651–656. 9 indexed citations
16.
Abou‐Gharbia, Magid, et al.. (1984). Tetrahydropyrrolo[1,2-a]quinoxalines and tetrahydropyrrolo[1,2-a]pyrido[3,2-a]pyrazines: vascular smooth muscle relaxants and antihypertensive agents. Journal of Medicinal Chemistry. 27(12). 1743–1746. 20 indexed citations
17.
Shropshire, Allen T. & Robert L. Wendt. (1983). Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.. Journal of Pharmacology and Experimental Therapeutics. 224(3). 494–500. 15 indexed citations
18.
Kim, Dong, et al.. (1983). (Mercaptopropanoyl)indoline-2-carboxylic acids and related compounds as potent angiotensin converting enzyme inhibitors and antihypertensive agents. Journal of Medicinal Chemistry. 26(3). 394–403. 42 indexed citations
19.
Ruelius, Hans W., et al.. (1980). Relationship of guanabenz concentrations in brain and plasma to antihypertensive effect in the spontaneously hypertensive rat.. Journal of Pharmacology and Experimental Therapeutics. 214(3). 594–598. 19 indexed citations
20.
Wendt, Robert L.. (1972). SYSTEMIC AND CORONARY VASCULAR EFFECTS OF THE 2- AND THE 5-MONONITRATE ESTERS OF ISOSORBIDE. Journal of Pharmacology and Experimental Therapeutics. 180(3). 732–742. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Kazda Breakdown of academic impact, for papers by S. F. Flaim Breakdown of academic impact, for papers by Kozo Yao Breakdown of academic impact, for papers by R. A. Ferrone Breakdown of academic impact, for papers by Bühler Fr Breakdown of academic impact, for papers by A. Van de Water Breakdown of academic impact, for papers by R. Testa Breakdown of academic impact, for papers by B Garthoff Breakdown of academic impact, for papers by Erich O. Mikkelsen Breakdown of academic impact, for papers by Morley C. Sutter
Rankless by CCL
2026